Age-related loss of muscle mass and bone strength in mice is associated with a decline in physical activity and serum leptin

Bone

Volumn 39, Issue 4, 2006, Pages 845-853

  Hamrick, Mark W ^a   Ding, Ke Hong ^a   Pennington, Catherine ^a   Chao, Yuh J ^c   Wu, Yii Der ^c   Howard, Boyd ^d   Immel, David ^d   Borlongan, Cesario ^a   McNeil, Paul L ^a   Bollag, Wendy B ^a   Curl, Walton W ^a   Yu, Jack ^a   Isales, Carlos M ^a,b  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c University of South Carolina   (United States)

^d SAVANNAH RIVER NATIONAL LABORATORY   (United States)

Author keywords

Aging; Bone loss; Bone mineral density; IL 6; Sarcopenia

Indexed keywords

LEPTIN;

AGE DISTRIBUTION; AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY FAT; BODY WEIGHT; BONE DENSITY; BONE STRENGTH; CELL STRUCTURE; CONTROLLED STUDY; CROSS LINKING; EVALUATION; MALE; MOLECULAR DYNAMICS; MOUSE; MUSCLE; MUSCLE MASS; NONHUMAN; OSTEOLYSIS; PHYSICAL ACTIVITY; TESTOSTERONE BLOOD LEVEL;

AGE FACTORS; ANIMALS; BIOMECHANICS; BLOOD GLUCOSE; BODY COMPOSITION; BODY MASS INDEX; BODY WEIGHT; BONE AND BONES; BONE DENSITY; INTERLEUKIN-6; LEPTIN; MALE; MICE; MICE, INBRED C57BL; MICROSCOPY, CONFOCAL; MODELS, ANIMAL; MOTOR ACTIVITY; MUSCLE CONTRACTION; MUSCLE, SKELETAL; OSTEOCALCIN; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33748193352     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2006.04.011     Document Type: Article

References (35)

1. Priemel M., Schilling A., Haberland M., Pogoda P., Rueger J., and Amling M. Osteopenic mice: animal models of the aging skeleton. J. Musculoskelet. Neuronal. Interact. 2 (2002) 212-218
2. Halloran B., Ferguson V., Simske S., Burghardt A., Venton L., and Majumdar S. Changes in bone structure and mass with advancing age in the male C57BL/6J mouse. J. Bone Miner. Res. 17 (2002) 1044-1050
3. Ferguson V., Ayers R., Bateman T., and Simske S. Bone development and age-related bone loss in male C57BL/6J mice. Bone 33 (2003) 387-398
4. Silva M.J., Brodt M., and Uthgenannt B. Morphological and mechanical properties of caudal vertebrae in the SAMP6 mouse model of senile osteoporosis. Bone 35 (2004) 425-431
5. Chen H., Shoumura S., and Emura S. Ultrastructural changes in bones of the senescence-accelerated mouse (SAMP6): a murine model for senile osteoporosis. Histol. Histopathol. 19 (2004) 677-685
6. Silva M.J., Brodt M.D., and Ettern S.L. Long bones from the senescence accelerated mouse SAMP6 have increased size but reduced whole-bone strength and resistance to fracture. J. Bone Miner. Res. 17 (2002) 1597-15603
7. Greenlund L., and Nair K. Sarcopenia-Consequences, mechanisms, and potential therapies. Mech. Aging Dev. 124 (2003) 287-299
8. Reid I., Plank L., and Evans M. Fat mass is an important determinant of whole body bone density in premenopausal women but not in men. J Clin Endocrinol Metab 74 (1992) 779-782
9. Galvard H., Elmstahl S., Elmstahl B., Samuellson S., and Robertsson E. Differences in body composition between female geriatric hip fracture patients and healthy controls: body fat is more important as an explanatory factor for the fracture than body weight and lean body mass. Aging Clin. Exp. Res. 8 (1996) 282-286
10. Grodin J., Siiteri P., and MacDonald P. Source of estrogen production in postmenopausal women. J. Clin. Endocrinol. Metab. 36 (1973) 207-214
11. Reid I. Relationships among body mass, its components, and bone. Bone 13 (2002) 547-555
12. Cornish J., Callon K., Bava U., Lin C., Naot D., and Hill B. Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo. J. Endocrinol. 175 (2002) 405-415
13. Hamrick M., Della-Fera M.A., Choi Y.-H., Pennington C., Hartzell D., and Baile C.A. Leptin treatment induces loss of bone marrow adipocytes and increases bone formation in leptin-deficient ob/ob mice. J. Bone Miner. Res. 20 (2005) 994-1001
14. Roubenoff R. Catabolism of aging: is it an inflammatory process?. Curr. Opin. Clin. Nutr. Metab. Care 6 (2003) 295-299
15. Turturro A., Witt W., Lewis S., Hass B., Lipman R., and Hart R. Growth curves and survival characteristics of the animals used in the biomarkers of aging program. J. Gerontol. 11 (1999) B492-B501
16. Borlongan C.V., Martinez R., Shytle R.D., Freeman T.B., Cahill D.W., and Sanberg P.R. Striatal dopamine mediated motor behavior is altered following occlusion of the middle cerebral artery. Pharmacol. Biochem. Behav. 52 (1995) 225-229
17. Borlongan C.V., Cahill D.W., and Sanberg P.R. Locomotor and passive avoidance deficits following occlusion of the middle cerebral artery. Physiol. Behav. 58 (1995) 909-917
18. Wang J.Y., Wu J.N., Cherng T.L., Hoffer B.J., Chen H.H., Borlongan C.V., et al. Vitamin D(3) attenuates 6-hydroxydopamine-induced neurotoxicity in rats. Brain Res. 904 (2001) 67-75
19. Xie D., Hua C., Hamrick M., Zhong Q., Ding K.-H., Correa D., et al. Glucose-dependent insulinotropic polypeptide receptor knockout mice have altered bone turnover. Bone 37 (2005) 759-769
20. Schriefer J., Robling A., Warden S., Fournier A., Mason J., and Turner C. A comparison of mechanical properties derived from multiple skeletal sites in mice. J. Biomech. 38 (2005) 467-475
21. Parfitt A.M., Drezner M., Glorieux F., Kanis J., Malluche H., Meunier P., et al. Bone histomorphometry: standardization of nomenclature, symbols, units. J. Bone Miner. Res. 2 (1987) 595-610
22. Hamrick M.W., Pennington C., Newton D., Xie D., and Isales C.M. Leptin deficiency produces contrasting phenotypes in bones of the limb and spine. Bone 34 (2004) 376-383
23. Ducy P., Amling M., Takeda S., Priemel M., Schilling A., Beil F., et al. Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 100 (2000) 197-207
24. Roubenoff R. Sarcopenic obesity: does muscle loss cause fat gain?. Ann. N. Y. Acad. Sci. 904 (2000) 553-557
25. Petersen A., and Pedersen B. The anti-inflammatory effect of exercise. J. Appl. Physiol. 98 (2005) 1154-1162
26. Fried S., Bunkin D., and Greenberg A. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J. Clin. Endocrinol. Metab. 83 (1998) 847-850
27. Roodman G. Interleukin-6: an osteotropic factor?. J. Bone Miner. Res. 7 (1992) 475-478
28. Franchimont N., Wertz S., and Malaise M. Interleukin 6: an osteotropic factor influencing bone formation?. Bone 37 (2005) 601-606
29. Payette H., Roubenoff R., Jacques P.F., Dinarello C., Wilson P., et al. Insulin-like growth factor-1 and interleukin 6 predict sarcopenia in very old community-living men and women: the Framingham Heart Study. J. Am. Geriatr. Soc. 51 (2003) 1237-1243
30. Aparicio L., Jurkovic M., and DeLullo J. Decreased bone mineral density in ambulatory patients with Duchenne muscular dystrophy. J. Pediatr. Orthop. 22 (2002) 179-181
31. Burr D.B. Muscle strength, bone mass, and age-related bone loss. J. Bone Miner. Res. 12 (1997) 1547-1551
32. Hamrick M. Leptin, bone mass, and the thrifty phenotype. J. Bone Miner. Res. 19 (2004) 1607-1611
33. Cannon J.G. Intrinsic and extrinsic factors in muscle aging. Ann. N. Y. Acad. Sci. 854 (1995) 72-77
34. Smerdely P., Seller M., Smith A., Day P., and Diamond T. Predictors of bone mass in healthy older men in the community. Med. J. Aust. 173 (2000) 183-186
35. Winters K., and Snow C. Body composition predicts bone mineral density and balance in premenopausal women. J. Women's Health Gend. -Based Med. 9 (2000) 865-872